Differential regulation of soluble guanylyl cyclase expression and signaling by collagens: Involvement of integrin-linked kinase

Journal of the American Society of Nephrology

Volumn 16, Issue 9, 2005, Pages 2626-2635

  De Frutos, Sergio ^a,b   Saura, Marta ^a,b   Griera, Mercedes ^a,b   Rivero Vilches, Francisco Javier ^a,b   Zaragoza, Carlos ^b   Rodriguez Puyol, Diego ^b   Rodriguez Puyol, Manuel ^a,b  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTEGRIN; ALPHA2 INTEGRIN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; CYCLIC GMP; DACTINOMYCIN; GUANYLATE CYCLASE; INTEGRIN LINKED KINASE; MESSENGER RNA; NITRIC OXIDE; PHOSPHOPROTEIN; BETA1 INTEGRIN; COMPLEMENTARY DNA; HYDROGEN PEROXIDE; INTEGRIN-LINKED KINASE; PROTEIN SERINE THREONINE KINASE;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; BIOLOGICAL MODEL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; MESANGIUM; METABOLISM; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; SOLUBILITY;

ANTIGENS, CD29; BASE SEQUENCE; CELLS, CULTURED; COLLAGEN; COLLAGEN TYPE I; COLLAGEN TYPE IV; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLOMERULAR MESANGIUM; GUANYLATE CYCLASE; HUMANS; HYDROGEN PEROXIDE; MODELS, BIOLOGICAL; NITRIC OXIDE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; SOLUBILITY;

EID: 33644789902     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004070587     Document Type: Article

References (48)

1. Stockand JD, Sansom SC: Regulation of filtration rate by glomerular mesangial cells in health and diabetic renal disease. Am J Kidney Dis 29: 971-981, 1997
2. Rosenblum ND: The mesangial matrix in the normal and sclerotic glomerulus. Kidney Int 45: S73-S77, 1994
3. Giancotti FG, Ruoslahti E: Integrin signalling. Science 258: 1028-1032, 1999
4. Kornberg L, Earp HS, Parsons JT, Schaller M, Juliano RL: Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J Biol Chem 267: 23439-23442, 1992
5. Wu C, Dedhar S: Integrin-linked kinase (ILK) and its interactors: A new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol 155: 505-510, 2001
6. Guo L, Sanders PW, Woods A, Wu C: The distribution and regulation of integrin-linked kinase in normal and diabetic kidneys. Am J Pathol 159: 1735-1742, 2001
7. Ortega-Velazquez R, Gonzalez-Rubio M, Ruiz-Torres MP, Diez-Marques ML, Iglesias MC, Rodriguez-Puyol M, Rodriguez-Puyol D: Collagen I upregulates extracellular matrix gene expression and secretion of TGF-beta 1 by cultured human mesangial cells. Am J Physiol Cell Physiol. 286: C1335-C1343, 2004
8. Makino H, Sugiyama H, Kashihara N: Apoptosis and extracellular matrix-cell interactions in kidney disease. Kidney Int Suppl 77: S67-S75, 2000
9. Morris ST, Jardine AG: The vascular endothelium in chronic renal failure. J Nephrol 13: 96-105, 2000
10. Trachtman H, Futterweit S, Singhal P: Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells. Biochem Biophys Res Commun 207: 120-125, 1995
11. Yao J, Schoecklmann HO, Prols F, Gauer S, Sterzel RB: Exogenous nitric oxide inhibits mesangial cell adhesion to extracellular matrix components. Kidney Int 53: 598-608, 1998
12. Stockand JD, Sansom SC: Glomerular mesangial cells: Electrophysiology and regulation of contraction. Physiol Rev 78: 723-744, 1998
13. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, Waldman SA: Guanylyl cyclases and signalling by cyclic GMP. Pharmacol Rev 52: 375-414, 2000
14. Cattell V: Nitric oxide and glomerulonephritis. Kidney Int 61: 816-821, 2002
15. Lloyd Jones D, Bloch K: The vascular biology of nitric oxide: Its role in atherogenesis. Annu Rev Med 47: 365-375, 1996
16. Ono H, Ono Y, Takanohashi A, Matsuoka H, Frohlich ED: Apoptosis, glomerular injury after prolonged nitric oxide synthase inhibition in spontaneously hypertensive rats. Hypertension 38: 1300-1306, 2001
17. Gabbai FB: Effects of nitric oxide synthase blockers on renal function. Nephrol Dial Transplant 16[Suppl 1]: 10-13, 2001
18. Eberhardt W, Beeg T, Beck KF, Walpen S, Gauer S, Bohles H, Pfeilschifter J: Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells. Kidney Int 57: 59-69, 2000
19. Eagleton MJ, Peterson DA, Sullivan VV, Roelofs KJ, Ford JA, Stanley JC, Upchurch GR Jr: Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression. J Surg Res 104: 15-21, 2002
20. Modlinger PS, Wilcox CS, Aslam S: Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin Nephrol 24: 354-365, 2004
21. Gonzalez-Santiago L, Lopez-Ongil S, Rodriguez-Puyol M, Rodriguez-Puyol D: Decreased nitric oxide synthesis in human endothelial cells cultured on type I collagen. Circ Res 90: 539-545, 2002
22. Diez-Marques ML, Garcia-Escribano C, Medina J, Boyano-Adanez MC, Arilla E, Torrecilla G, Rodriguez-Puyol D, Rodriguez-Puyol M: Effects of somatostatin on cultured human mesangial cells. Endocrinology 136: 3444-3451, 1995
23. Garcia-Escribano C, Diez-Marques ML, Gonzalez-Rubio M, Rodriguez-Puyol M, Rodriguez-Puyol D: Somatostatin antagonizes angiotensin II effects on mesangial cell contraction and glomerular filtration. Kidney Int 43: 324-333, 1993
24. Iglesias-De La Cruz MC, Ruiz-Torres MP, De Lucio-Cazana FJ, Rodriguez-Puyol M, Rodriguez-Puyol D: Phenotypic modifications of human mesangial cells by extracellular matrix: The importance of matrix in the contractile response to reactive oxygen species. Exp Nephrol 8: 97-103, 2000
25. Troussard AA, Tan C, Yoganathan TN, Dedhar S: Cell-extracellular matrix interactions stimulate the AP-1 transcription factor in an integrin-linked kinase and glycogen synthase kinase 3-dependent manner. Mol Cell Biol 19: 7420-7427, 1999
26. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
27. Giuili G, Scholl U, Bulle F, Guellaen G: Molecular cloning of the cDNAs coding for the two subunits of soluble guanylyl cyclase from human brain. FEBS Lett 304: 83-88, 1992
28. Rivero-Vilches FJ, de Frutos S, Saura M, Rodriguez-Puyol D, Rodriguez-Puyol M: Differential relaxing responses to particulate or soluble guanylyl cyclase activation on endothelial cells: A mechanism dependent on PKG-I alpha activation by NO/cGMP. Am J Physiol Cell Physiol 285: C891-C898, 2003
29. Ortega-Velazquez R, Diez-Marques ML, Ruiz-Torres MP, Gonzalez-Rubio M, Rodriguez-Puyol M, Rodriguez Puyol D: Arg-Gly-Asp-Ser peptide stimulates transforming growth factor-beta1 transcription and secretion through integrin activation. FASEB J 11: 1529-1531, 2003
30. Iglesias-De La Cruz MC, Ruiz-Torres P, Alcami J, Diez-Marques ML, Ortega-Velázquez R, Chen S, Rodriguez-Puyol M, Ziyadeh FN, Rodriguez-Puyol D: Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells. Kidney Int 59: 87-95, 2001
31. Yang ZW, Zheng T, Zhang A, Altura BT, Altura BM: Mechanisms of hydrogen peroxide-induced contraction of rat aorta. Eur J Pharmacol 344: 169-181, 1998
32. Torrecillas G, Boyano-Adanez MC, Medina J, Parra T, Griera M, Lopez-Ongil S, Arilla E, Rodriguez-Puyol M, Rodriguez-Puyol D: The role of hydrogen peroxide in the contractile response to angiotensin II. Mol Pharmacol 59: 104-112, 2001
33. Ibarra-Alvarado C, Galle J, Melichar VO, Mameghani A, Schmidt HH: Phosphorylation of blood vessel vasodilator-stimulated phosphoprotein at serine 239 as a functional biochemical marker of endothelial nitric oxide/cyclic GMP signaling. Mol Pharmacol 61: 312-319, 2002
34. Miralem T, Whiteside CI, Templeton DM: Collagen type I enhances endothelin-mediated contraction and induces nonproliferating phenotype in mesangial cells. Am J Physiol 270: F960-F970, 1996
35. Buschhausen L, Seibold S, Gross O, Matthaeus T, Weber M, Schulze-Lohoff E: Regulation of mesangial cell function by vasodilatory signalling molecules. Cardiovasc Res 51: 463-469, 2001
36. Filippov G, Bloch BD, Bloch KD: Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells. J Clin Invest 100: 942-948, 1997
37. Papapetropoulos A, Marczin N, Mora G, Milici A, Murad F, Catravas JD: Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents. Hypertension 26: 696-704, 1995
38. de Frutos S, Saura M, Rivero-Vilches FJ, Rodriguez-Puyol D, Rodriguez-Puyol M: C-type natriuretic peptide decreases soluble guanylate cyclase levels by activating the proteasome pathway. Biochim Biophys Acta 1643: 105-112, 2003
39. Papapetropoulos A, Abou-Mohammed G, Marczin N, Murad F, Caldwell RW, Catravas J: Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1beta. Br J Pharmacol 118: 1359-1366, 1996
40. Liu H, Force T, Bloch KD: Nerve growth factor decreases soluble guanylate cyclase in rat pheochromocytoma PC12 cells. J Biol Chem 272: 6038-6043, 1997
41. Sharina IG, Krumenacker JS, Martin E, Murad F: Genomic organization of alpha1 and beta1 subunits of the mammalian soluble guanylyl cyclase genes. Proc Natl Acad Sci U S A 97: 10878-10883, 2000
42. Sharina IG, Martin E, Thomas A, Uray KL, Murad F: CCAAT-binding factor regulates expression of the beta1 subunit of soluble guanylyl cyclase gene in the BE2 human neuroblastoma cell line. Proc Natl Acad Sci U S A 100: 11523-11528, 2003
43. Xu Y, Gurusiddappa S, Rich RL, Owens RT, Keene DR, Mayne R, Hook A, Hook M: Multiple binding sites in collagen type I for the integrins a1b1 and a2b1. J Biol Chem 275: 38981-38989, 2000
44. Dickenson SK, Mathis NL, Santoro SA: Determinants of ligand binding specificity of the a1b1 integrins. J Biol Chem 274: 33182-33191, 1999
45. Dedhar S, Williams B, Hannigan G: Integrin-linked kinase (ILK): A regulator of integrin and growth-factor signalling. Trends Cell Biol 9: 319-323, 1999
46. Novak A, Hsu S, Leung-Hagesteijn CY, Radeva G, Papkoff J, Montesano R, Roskelley C, Grosschedl R, Dedhar S: Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signalling pathways. Proc Natl Acad Sci U S A 95: 4374-4379, 1998
47. D'Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B, Fu M, Augenlicht LH, Donehower LA, Takemaru K, Moon RT, Davis R, Lisanti MP, Shtutman M, Zhurinsky J, Ben-Ze'ev A, Troussard AA, Dedhar S, Pestell RG: The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem 275: 32649-32657, 2000
48. Tan C, Mui A, Dedhar S: Integrin-linked kinase regulates inducible nitric oxide synthase and cyclooxygenase-2 expression in an NF-kappa B-dependent manner. J Biol Chem 277: 3109-3116, 2002